Evidence map›Paper›PMID 27466161›Full record

ReviewInternational journal of cancer2017

Informing etiologic research priorities for squamous cell esophageal cancer in Africa: A review of setting-specific exposures to known and putative risk factors.

V A McCormack, D Menya, M O Munishi, C Dzamalala, N Gasmelseed, M Leon Roux, M Assefa, O Osano, M Watts, A O Mwasamwaja and 5 more

Open access · bronzeAbstract readReview
In one paragraph

Review in International journal of cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 2 pooled it
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 2 syntheses or guidelines pooled it, 147 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Integrative systems biology analysis reveals diagnostic and prognostic DNA methylation signatures in esophageal cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 9 countries.

V A McCormackSection of Environment and Radiation, International Agency for Research on Cancer (IARC), Lyon, France.
D MenyaSchool of Public Health, Moi University, Eldoret, Kenya.
M O MunishiKilimanjaro Clinical Research Institute, Moshi, Tanzania.
C DzamalalaCollege of Medicine, University of Malawi, Blantyre, Malawi.
N GasmelseedNational Cancer Institute, University of Gezira, Sudan.
M Leon RouxSection of Environment and Radiation, International Agency for Research on Cancer (IARC), Lyon, France.
M AssefaRadiotherapy Center, Addis-Ababa-University, Addis Ababa, Ethiopia.
O OsanoSchool of Environmental Studies, University of Eldoret, Kenya.
M WattsInorganic Chemistry, Centre for Environmental Geochemistry, British Geological Survey, Nottingham, United Kingdom.
A O MwasamwajaKilimanjaro Clinical Research Institute, Moshi, Tanzania.
B T MmbagaKilimanjaro Clinical Research Institute, Moshi, Tanzania.
G MurphyDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
C C AbnetDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
S M DawseyDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
J SchüzSection of Environment and Radiation, International Agency for Research on Cancer (IARC), Lyon, France.
Centre International de Recherche sur le Cancer · FRKilimanjaro Christian Medical Centre · TZNational Cancer Institute · USAddis Ababa University · ETBritish Geological Survey · GBMoi University · KEUniversity of Eldoret · KEUniversity of Hafr Al-Batin · SAUniversity of Malawi · MW

Funding

Upper Gastrointestinal Cancer StudiesZIACP000185 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ABNET, CHRISTIAN · 2009 to 2025
$25.6M
Esophageal cancer in West KenyaR21CA191965 · NCI · INTERNATIONAL AGENCY FOR RES ON CANCER · PI MCCORMACK, VALERIE · 2015 to 2016
$256k
Intramural NIH HHS ZIA CP000185NCI NIH HHS R21 CA191965World Health Organization 001
6 · The paper itself

Abstract

Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers in most Eastern and Southern African countries, but its etiology has been understudied to date. To inform its research agenda, we undertook a review to identify, of the ESCC risk factors which have been established or strongly suggested worldwide, those with a high prevalence or high exposure levels in any ESCC-affected African setting and the sources thereof. We found that for almost all ESCC risk factors known to date, including tobacco, alcohol, hot beverage consumption, nitrosamines and both inhaled and ingested PAHs, there is evidence of population groups with raised exposures, the sources of which vary greatly between cultures across the ESCC corridor. Research encompassing these risk factors is warranted and is likely to identify primary prevention strategies.

Indexed as

AfricaAnimalsCarcinoma, Squamous CellEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaHumansPrevalenceRisk FactorsAfricaesophageal cancerrisk factors

Identifiers

PMID27466161
PMCPMC5763498
OpenAlexW2498679987

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.